Free Trial
NASDAQ:BKYI

BIO-key International Q3 2023 Earnings Report

BIO-key International logo
$0.83 0.00 (-0.54%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$0.83 +0.00 (+0.42%)
As of 07/18/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BIO-key International EPS Results

Actual EPS
-$1.44
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BIO-key International Revenue Results

Actual Revenue
$1.83 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BIO-key International Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Wednesday, October 25, 2023
Conference Call Time
7:00AM ET

Upcoming Earnings

BIO-key International's Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 14, 2025 at 10:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BIO-key International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BIO-key International and other key companies, straight to your email.

About BIO-key International

BIO-key International (NASDAQ:BKYI), Inc. (NASDAQ: BKYI) is a provider of biometric identity management and multi‐factor authentication solutions designed to secure access to digital resources. The company’s core business revolves around the development, marketing and support of fingerprint recognition hardware and software, as well as cloud‐based and on‐premise identity and access management (IAM) platforms. BIO-key’s suite of products enables organizations to replace or supplement traditional password systems with more secure, user‐friendly biometric authentication methods.

The company’s flagship offerings include biometric readers, software development kits (SDKs) and PortalGuard, a comprehensive IAM solution that integrates single sign‐on, multi‐factor authentication and self‐service credential management. BIO-key’s fingerprint readers are FIPS 201‐compliant and cater to enterprise IT, healthcare, government and financial services customers. Its cloud‐native and on‐premises deployment models provide flexibility, enabling clients to implement biometric security without overhauling existing infrastructure.

Founded in 1996 and headquartered in Farmingdale, New York, BIO-key International has expanded its reach through strategic partnerships and distribution agreements across North America, Europe and the Asia‐Pacific region. Over its history, the company merged with various technology firms to bolster its product portfolio and broaden its addressable market. Its publicly traded status since 2005 has supported ongoing investments in research and development, with a focus on mobile biometric applications and next‐generation authentication techniques.

Under the leadership of President and Chief Executive Officer Michael DePasquale IV, BIO-key has pursued growth through innovation and targeted acquisitions. Management emphasizes compliance with industry security standards and the delivery of scalable solutions that reduce password‐related help‐desk costs and strengthen overall cybersecurity posture. As demand for stronger identity verification intensifies, BIO-key continues to position itself as a specialist in frictionless, biometric‐first authentication technologies.

View BIO-key International Profile

More Earnings Resources from MarketBeat